FDA approves drug to treat hypertension

The Food and Drug Administration approved Jubilant Life Sciences’ new drug for the treatment of hypertension.

Advertisement

Telmisartan tablets represent a generic version of Boehringer Ingelheim Pharmaceuticals’ Micardis tablets.

As of June 30, India-based Jubilant holds 70 drug applications filed through the FDA, 44 of which have been approved.

More articles on supply chain:

Medical device, drug recalls soar in Q2
AMA urges Mylan to lower cost of EpiPens
Mylan vows to reduce patient costs in light of EpiPen pricing scandal

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.